Montreal, August 14, 2021 – While vaccine booster campaigns are being planned in certain countries around the world for at-risk populations, researchers at the University of Montreal Hospital Research Centre (CRCHUM) have measured humoral responses elicited by the COVID-19 vaccine in people living with HIV.
Montréal, May 20, 2021 — Researchers at the University of Montreal Hospital Research Centre (CRCHUM) and Yale University have succeeded in reducing the size of the HIV reservoir in humanized mice by using a “molecular can opener” and a combination of antibodies found in the blood of infected individuals.
For the first time in Canada, a team from the CHUM Research Centre (CRCHUM) will study the efficacy of a therapy combining intestinal microbiota and immunotherapy to treat melanoma.
At the CRCHUM Conference on March 12th, we will honour André Robidoux, M.D., who passed away on July 25, 2020, from an incurable cancer.
As part of a large research project to evaluate the protective effect of vitamin D against COVID-19, CHU Sainte-Justine (CHUSJ) and the Centre hospitalier de l’Université de Montréal (CHUM) are seeking healthcare staff who have direct contact with patients or colleagues and who wish to participate in this important work.
Eighty-five per cent of staffers in hospitals and long-term-care centres coped well with the mental stress they experienced during and after the first wave of the COVID-19 pandemic last year.
Anne-Marie Mes-Masson, a researcher with the CHUM Research Centre’s Cancer Research Theme, has received the 2020 Acfas Léo-Pariseau Award.
A regular researcher with the CHUM Research Centre’s Cancer Research Theme, Anne-Marie Mes-Masson joined the ranks of Canada’s Most Powerful Women: Top 100 this year, in the Science and Technology category.